Endophthalmitis

Current Clinical Topics in Infectious Diseases

Volumn , Issue 20, 2000, Pages 271-297

  Durand, Marlene L ^a   Heier, Jeffrey S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

CANDIDA ALBICANS; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ENDOPHTHALMITIS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; POLYMERASE CHAIN REACTION; PREDICTION AND FORECASTING; REVIEW; TOPICAL DRUG ADMINISTRATION; VISUAL ACUITY; VITRECTOMY;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; CANDIDA ALBICANS; DIAGNOSIS, DIFFERENTIAL; ENDOPHTHALMITIS; HUMANS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; ULTRASONOGRAPHY; VISUAL ACUITY; VITRECTOMY;

EID: 0034565343     PISSN: 01953842     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (113)

1. Mandelbaum S, Forster RK. Exogenous endophthalmitis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular infection and immunity. St. Louis: Mosby, 1996;1298-1320.
2. Theodore FH. Bacterial endophthalmitis after cataract surgery. Int Ophthalmol Clin 1964;4:839-859.
3. Forster RK. Endophthalmitis: diagnostic cultures and visual results. Arch Ophthalmol 1974;92:387-392.
4. Forster RK, Abbott RL, Gelender H. Management of infectious endophthalmitis. Ophthalmology 1980;87:313-319.
5. Peyman GA, Vastine DW, Crouch ER, Herbst RW Jr. Clinical use of intravitreal antibiotics to treat bacterial endophthalmitis. Trans Am Acad Ophthalmol Otolaryngol 1974;78:862-875.
6. von Sallmann L. Penicillin therapy of infections of the vitreous. Arch Ophthalmol 1945;33:455-462.
7. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479.
8. Maylath FR, Leopold JH. Study of experimental ocular infection. Am J Ophthalmol 1955;40:86-101.
9. Dickey JB, Thompson KD, Jay WM. Anterior chamber aspirate cultures after uncomplicated cataract surgery. Am J Ophthalmol 1991;112:278.
10. Sherwood DR, Rich WJ, Jacob JS, et al. Bacterial contamination of intraocular and extraocular fluids during extracapsular cataract extraction. Eye 1989;3:308-311.
11. Irvine WD, Flynn HW Jr, Murray TG, Rubsamen PE. Retained lens fragments after phacoemulsification manifesting as marked intraocular inflammation with hypopyon. Am J Ophthalmol 1992;114:610-614.
12. Kim JE, Flynn HW Jr, Rubsamcn PE, et al. Endophthalmitis in patients with retained lens fragments after phacoemulsification. Ophthalmology 1996;103:575-578.
13. Jalali S, Das T, Gupta S. Presumed non-infectious endophthalmitis after cataract surgery. J Cataract Refract Surg 1996;22: H92-H97.
14. Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 1993; 100:1399-1406.
15. Lopez JF, Alvarcz JC. Atypical echographic forms of retinoblastomas. J Pediatr Ophthalmol Strabismus 1983;20:230-234.
16. Shields JA, Shields CL, Eagle RC Jr, et al. Endogenous endophthalmitis simulating retinoblastoma. The 1993 David and Mary Seslen Endowment Lecture. Retina 1995;15: 213-219.
17. Foster BS, Mukai S. Intraocular retinoblastoma presenting as ocular and orbital inflammation. Int Ophthalmol Clin 1996;36: 153-160.
18. Verbraeken H. Diagnostic vitrectomy and chronic uveitis. Graefes Arch Clin Exp Ophthalmol 1996;234(suppl 1):S2-S7.
19. Marchini G, Pagliarusco A, Tosi R, Castagna G. Ultrasonographic findings in endophthalmitis. Acta Ophthalmol Scand 1995;73:446-449.
20. Chan IM, Jalkh AE, Trempe CL, Tolentino FI. Ultrasonographic findings in endophthalmitis. Annals Ophthalmol 1984;16:778-784.
21. Dacey MP, Valencia M, Lee MB, et al. Echographic findings in infectious endophthalmitis. Arch Ophthalmol 1994;112:1325-1333.
22. Okada M, Johnson RP, Liles WC, et al. Endogenous bacterial endophthalmitis: report of a ten-year retrospective study. Ophthalmology 1994;101:832-838.
23. Barza M, Pavan PR, Doft BH, et al. Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 1997;115:1142-1150.
24. Durfee K, Smith JP. Use of Gram's stain to predict vitreous fluid infection. Am J Med Technol 1982;48:525-529.
25. Joondeph BC, Flynn HW Jr, Miller D, Joondeph HC. A new culture method for infectious endophthalmitis. Arch Ophthalmol 1989;107:1334-1337.
26. Donahue SP, Kowalski RP, Jewart BH, Fribcrg TR. Vitreous cultures in suspected endophthalmitis. Biopsy or vitrectomy? Ophthalmology 1993;100:452-455.
27. Mames RN, Friedman SM, Stinson WG, Margo CE. Positive vitreous cultures from eyes without signs of infectious endophthalmitis. Ophthalmic Surg Lasers 1997;28: 365-369.
28. Dhaliwal DK, Kowalski RP, Donahue SP, et al. Evaluation of vitrectomy machines as a source of false-positive culture contamination in endophthalmitis. Am J Ophthalmol 1995; 119:62-64.
29. Therese KL, Anand AR, Madhavan HN. Polymerase chain reaction in the diagnosis of bacterial endophthalmitis. Br J Ophthalmol 1998;82:1078-1082.
30. Lohmann CP, Gabel VP, Heeb M, et al. Listeria monocytogenes-induced endogenous endophthalmitis in an otherwise healthy individual: rapid PCR-diagnosis as the basis for effective treatment. Eur J Ophthalmol 1999; 9:53-57.
31. Lohmann CP, Heeb M, Linde HJ, et al. Diagnosis of infectious endophthalmitis after cataract surgery by polymerase chain reaction. J Cataract Refract Surg 1998;24:821-826.
32. Hykin PG, Tobal K, McIntyre G, et al. The diagnosis of delayed post-operative endophthalmitis by polymerase chain reaction of bacterial DNA in vitreous samples. J Med Microbiol 1994;40:408-415.
33. Cottingham AJ Jr, Forster RK. Vitrectomy in endophthalmitis: results of a study using vitrectomy, intraocular antibiotics, or a combination of both. Arch Ophthalmol 1976;94: 2078-2081.
34. Talley RP, D'Amico DJ, Talamo JH, et al. The role of vitrectomy in treatment of post-operative bacterial endophthalmitis. Arch Ophthalmol 1987;105:1699-1702.
35. Aguilar HE, Meredith TA, Drews C, et al. Comparative treatment of experimental Staphylococcus aureus endophthalmitis. Am J Ophthalmol 1996;121:310-317.
36. Stern GA. Factors affecting the efficacy of antibiotics in the treatment of experimental postoperative endophthalmitis. Trans Am Ophthalmol Soc 1993;91:775-844.
37. Forster RK, Abbott RL, Gelender H. Management of infectious endophthalmitis. Ophthalmology 1980;87:313-319.
38. Driebe WT Jr, Mandelbaum S, Forster RK, et al. Pseudophakic endophthalmitis. Ophthalmology 1986;93:442-8.
39. Mao LK, Flynn HW Jr, Miller D, Pfugfelder SC. Endophthalmitis caused by Staphylococcus aureus. Am J Ophthalmol 1993;116:584-589.
40. Flynn HW Jr, Meredith TA. The Endophthalmitis Vitrectomy Study (letter). Arch Ophthalmol 1996;114:1027-108.
41. Han DP, Wisnienski SR, Kelsey SF, et al. Microbiologie yields and complication rates of vitreous needle aspiration versus mechanized vitreous biopsy in the Endophthalmitis Vitrectomy Study. Retina 1999;19:98-102.
42. Doft BH, Kelsey SF, Wisniewski SR, EVS Study Group. Additional procedures after the initial vitrectomy or TAP-biopsy in the Endophthalmitis Vitrectomy Study. Ophthalmology 1998;105:707-716.
43. Shaarawy A, Grand MG, Meredith TA, Ibanez HE. Persistent endophthalmitis after intravitreal antimicrobial therapy. Ophthalmology 1995;102:382-387.
44. Campochiaro PA, Lim JI, Bloome MA, et al. Aminoglycoside toxicity in the treatment of endophthalmitis. Arch Ophthalmol 1994; 112:48-53.
45. Oum BS, D'Amico DJ, Wong KW. Intravitreal antibiotic therapy with vancomycin and aminoglycoside: an experimental study of combination and repetitive injections. Arch Ophthalmol 1989;107:1055-1060.
46. Fiscella RG, Gieser J, Phillpotts B, et al. Intraocular penetration of gentamicin after once-daily aminoglycoside dosing. Retina 1998;18:339-342.
47. el-Massry A, Meredith TA, Aguilar HE, et al. Aminoglycoside levels in the rabbit vitreous cavity after intravenous administration. Am J Ophthalmol 1996;122:684-689.
48. Verbraeken H, Verstraete A, Van de Velde E, Verschraegen G. Penetration of gentamicin and ofloxacin in human vitreous after systemic administration. Graefes Arch Clin Exp Ophthalmol 1996;234(suppl 1): S59-S65.
49. Ferencz JR, Assia EI, Diamantstein L, Rubinstein E. Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis. Arch Ophthalmol 1999;117:1023-1027.
50. Coco RM, Lopez MI, Pastor JC, Nozal MJ. Pharmacokinetics of intravitreal vancomycin in normal and infected rabbit eyes. J Ocul Pharmacol Ther 1998;14:555-563.
51. Aguilar HE, Meredith TA, el-Massry A, et al. Vancomycin levels after intravitreal injection. Effects of inflammation and surgery. Retina 1995;15:428-432.
52. Mandell BA, Meredith TA, Aguilar E, et al. Effects of inflammation and surgery on amikacin levels in the vitreous cavity. Am J Ophthalmol 1993;115:770-774.
53. Meredith TA. Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime. Trans Am Ophthalmol Soc 1993;91:653-699.
54. Meredith TA, Aquilar HE, Shaarawy A, et al. Vancomycin levels in the vitreous cavity after intravenous administration. Am J Ophthalmol 1995;119:774-778.
55. Haimann MH, Weiss H, Miller J. The Endophthalmitis Vitrectomy Study (letter). Arch Ophthalmol 1996;114:1025.
56. Weber DJ, Hoffman KL, Thoft RA, Baker AS. Endophthalmitis following intraocular lens implantation: report of 30 cases and review of the literature. Review Infect Dis 1986;8:12-20.
57. Barza M, Doft B, Lynch E. Ocular penetration of ceftriaxone, ceftazidime, and vancomycin after subconjunctival injection in humans. Arch Opthalmol 1993;111:492-494.
58. Graham RO, Peyman GA. Intravitreal injection of dexamethasone. Arch Ophthalmol 1974;92:149-154.
59. Park SS, Samiy N, Ruoff K, et al. Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits. Arch Ophthalmol 1995;113:1324-1329.
60. Meredith TA, Aguilar HE, Drews C, et al. Intraocular dexamethasone produces a harmful effect on treatment of experimental Staphylococcus aureus endophthalmitis. Trans Am Ophthalmol Soc 1996;94:252-257.
61. Das T, Jalali S, Gothwal VK, et al. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomized study. Br J Ophthalmol 1999;83: 1050-1055.
62. Alien HF, Mangiaracine AB. Bacterial endophthalmitis after cataract extraction. II. Incidence in 36,000 consecutive operations with special reference to preoperative topical antibiotics. Arch Ophthalmol 1974;91:3-7.
63. Javitt JC, Vitale S, Canner JK, et al. National outcomes of cataract extraction: endophthalmitis following inpatient surgery. Arch Ophthalmol 1991;109:1085-1089.
64. Aaberg TM Jr, Flynn HW, Schiffman J, Newton J. Nosocomial acute-onset post-operative endophthalmitis survey: a 10-year review of incidence and outcomes. Ophthalmology 1998;105:1004-1010.
65. Kattan HM, Flynn HW, Pflugfelder SC, et al. Nosocomial endophthalmitis survey: current incidence of infection after intraocular surgery. Ophthalmology 1991;98:227-238.
66. Javitt JC, Street DA, Tielsch JM, et al., on behalf of the Cataract Patient Out-comes Research Team. National outcomes of cataract extraction: retinal detachment and endophthalmitis after outpatient cataract surgery. Ophthalmology 1994;101:100-106.
67. Cruciani M, Malena M, Amalfitano G, et al. Molecular epidemiology in a cluster of cases of postoperative Pseudomonas aeruginosa endophthalmitis. Clin Infect Dis 1998; 26:330-3.
68. Centers for Disease Control and Prevention. Outbreaks of postoperative bacterial endophthalmitis caused by intrinsically contaminated ophthalmic solutions - Thailand, 1992, and Canada, 1993. MMWR 1996;45: 491-494.
69. Bannerman TL, Rhoden DL, McAllister SK, et al., for the Endophthalmitis Vitrectomy Study Group. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol 1997;115: 357-361.
70. Speaker MG, Milch FA, Shah MK, et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991;98:639-649.
71. Tervo T, Ljungberg P, Kautianinen T, et al. Prospective evaluation of external ocular microbial growth and aqueous humor contamination during cataract surgery. J Cataract Refract Surg 1999;25:65-71.
72. Mistlberger A, Ruckhofer J, Raithel E, et al. Anterior chamber contamination during cataract surgery with intraocular lens implantation. J Cataract Refract Surg 1997; 23:1064-1069.
73. Maxwell DP Jr, Brent BD, Orillac R, et al. A natural history study of experimental Staphylococcus epidermidis endophthalmitis. Curr Eye Res 1993;12:907-912.
74. Booth MC, Hatter KL, Miller D, et al. Molecular epidemiology of Staphylococcus aureus and Enterococcus faecalis in endophthalmitis. Infect Immun 1998;66:356-360.
75. Menikoff JA, Speaker MG, Marmor M, et al. A case-control study of risk factors for postoperative endophthalmitis. Ophthalmology 1991;98:1761.
76. Driebe WT Jr, Mandelbaum S, Forster RK, et al. Pseudophakic endophthalmitis: diagnosis and management. Ophthalmology 1986; 93:442.
77. Turkalj JW, Carlson AN, Manos JP, Apple DJ. Is the sutureless cataract incision a valve for bacterial inoculation? J Cataract Refract Surg 1995;21:472-476.
78. Endophthalmitis Vitrectomy Study Group. Microbiologic factors and visual outcome in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996;122:830-846.
79. Zambrano WZ, Flynn HW Jr, Pflugfelder SC, et al. Management options for Proprionibacterium acnes endophthalmitis. Ophthalmology 1989;96:1100-1105.
80. Meisler DM, Palestine AG, Vastine DW, et al. Chronic Propionibacterium endophthalmitis after extracapular cataract extraction and intraocular lens implantation. Am J Ophthalmol 1986;102:733-739.
81. Piest KL, Apple DJ, Kincaid MC, et al. Localized endophthalmitis: a newly described cause of the so-called toxic lens syndrome. J Cataract Refract Surg 1987;13: 498-510.
82. Ficker L, Meredith TA, Wilson LA, et al. Chronic bacterial endophthalmitis. Am J Ophthalmol 1987;103:745-748.
83. Rao NA, Nerenberg AV, Forster DJ. Torulopsis candida (Candida famata) endophthalmitis simulating Propionibacterium acnes syndrome. Arch Ophthalmol 1991;109:1718-1721.
84. Winward KE, Pflugfelder SC, Flynn HW Jr, et al. Postoperative Propionibacterium endophthalmitis. Treatment strategies and long-term results. Ophthalmology 1993;100: 447-451.
85. Thach AB, Das A, Lopez PF. En bloc capsulectomy in the diagnosis and treatment of refractory, chronic, recurrent pseudophakic endophthalmitis. Ophthalmic Surg 1994;25: 361-364.
86. Greenfield DS, Suner IJ, Miller MP, et al. Endophthalmitis after filtering surgery with mitomycin C. Arch Ophthalmol 1996;114: 943-949.
87. Higginbotham EJ, Stevens RK, Musch DC, et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 1996;103:650-656.
88. Kangas TA, Greenfield DS, Flynn HW, et al. Delayed-onset endophthalmitis associated with conjunctival filtering blebs. Ophthalmology 1997;104:746-752.
89. Ciulla TA, Beck AD, Topping TM, Baker AS. Blebitis, early endophthalmitis, and late endophthalmitis after glaucoma-filtering surgery. Ophthalmology 1997;104:986-995.
90. Mandelbaum S, Forster RK, Gelender H, Culbertson W. Late onset endophthalmitis associated with filtering blebs. Ophthalmology 1985;92:964-972.
91. Duch-Samper AM, Chaques-Alepuz V, Menezo JL, Hurtado-Sarrio M. Endophthalmitis following open-globe injuries. Curr Opin Ophthal 1998;9:59-65.
92. Thompson JT, Parver LM, Enger CL, et al., for the National Eye Trauma System. Infectious endophthalmitis after penetrating injuries with retained intraocular foreign bodies: National Eye Trauma System. Ophthalmology 1993;100:1468-1474.
93. Jonas JB, Budde WM. Early versus late removal of retained intraocular foreign bodies. Retina 1999;19:193-197.
94. Thompson WS, Rubsamen PE, Flynn HW Jr, et al. Endophthalmitis after penetrating ocular trauma: risk factors and visual acuity outcomes. Ophthalmology 1995;102:1696-1671.
95. Alfaro DV, Roth DB, Laughlin RM, et al. Paediatric post-traumatic endophthalmitis. Br J Ophthalmol 1995;79:888-891.
96. Davey RT JR, Tauber WB. Posttraumatic endophthalmitis: the emerging role of Bacillus cereus infection. Rev Infect Dis 1987;9: 110-123.
97. Foster RE, Martinez JA, Murray TG, et al. Useful visual outcomes after treatment of Bacillus cereus endophthalmitis. Ophthalmology 1996;103:390-397.
98. Reed M, Hibberd PL. Endoscopy and endophthalmitis. N Engl J Med 1989;321: 836.
99. Greenwald MJ, Wohl LG, Sell CH. Metastatic bacterial endophthalmitis: a contemporary reappraisal. Surv Ophthalmol 1986;31: 81-101.
100. Joshi N, Hamory BH. Endophthalmitis caused by non-albicans species of Candida. Rev Infect Dis 1991;13:281-287.
101. Scherer WJ, Lee K. Implications of early systemic therapy on the incidence of endogenous fungal endophthalmitis. Ophthalmology 1997;104:1593-1598.
102. Donahue SP. Intraocular candidiasis in patients with candidemia (letter). Ophthalmology 1998;105:759-760.
103. Brooks RG. Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med 1989;149: 2226-2228.
104. Donahue SP, Greven CM, Zuravleff JJ, et al. Intraocular candidiasis in patients with candidemia: clinical implications derived from a prospective multicenter study. Ophthalmology 1994;101:1302-1309.
105. Essman TF, Flynn HW, Smiddy WE, et al. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 1997;28:185-194.
106. Park SS, D'Amico DJ, Paton B, Baker AS. Treatment of exogenous Candida endophthalmitis in rabbits with oral fluconazole. Antimicrob Agents Chemother 1995;39:958-963.
107. Akler ME, Vellend H, McNecly DM, et al. Use of fluconazole in the treatment of candidal endophthalmitis. Clin Infect Dis 1995;20: 657-664.
108. Filler SG, Crislip MA, Mayer CL, Edwards JE. Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits. Antimicrob Agents Chemother 1991;35:288-292.
109. Nomura J, Ruskin J. Failure of therapy with fluconazole for candidat endophthalmitis. Clin Infect Dis 1993;17:888-889.
110. Pflugfelder SC, Flynn HW Jr, Zwickey TA, et al. Exogenous fungal endophthalmitis. Ophthalmology 1988;95:19-30.
111. Weishaar PD, Flynn HW Jr, Murray TG, et al. Endogenous Aspergillus endophthalmitis: clinical features and treatment out-comes. Ophthalmology 1998;105:57-65.
112. Hunt KE, Glasgow BJ. Aspergillus endophthalmitis: an unrecognized endemic disease in orthotopic liver transplantation. Ophthalmology 1996;103:757-767.
113. Ross RD. Is perception of light useful to the blind patient? Arch Ophthalmol 1998;116: 236-238.